AstraZeneca is a science‑led, patient‑focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. We are more than one of the world’s leading pharmaceutical companies. AstraZeneca has a multifaceted environment that cultivates collaboration and innovation. Within Hematology R&D, we are committed to advancing the science to deliver life‑changing medicines to patients most in need. With a combination‑focused pipeline that exploits the power of six scientific platforms (Immuno‑Oncology, Tumor Drivers and Resistance, DNA Damage Response, Antibody‑drug Conjugates, Cell Therapy and Epigenetics) to help address unmet clinical needs in a host of hematological cancers, we are motivated by a dedication to the scientific discovery and collaboration that will one day help eliminate cancer as a cause of death. This unit has responsibility for ...